查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1324913

人工唾液市場：現狀分析與預測（2022-2028）

Artificial Saliva Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

您的醫生可能還會建議將人工唾液與已知會導致口乾的藥物或醫療程序一起使用，例如止痛藥或化療。 例如，美國國家癌症研究所 (NIH) 估計，2022 年美國將有 1810 萬癌症倖存者。 這約佔總人口的 5.4%，預計到 2032 年將增加 24.4%，達到 2250 萬人。

由於癌症患者吞嚥困難的患病率不斷增加，人工唾液市場預計將以 13% 左右的速度穩定增長。 此外，發達國家和新興國家口腔疾病治療費用高昂、可支配收入增加和人均支出增加也將支持預測期內的市場增長。

根據產品類型，市場分為口腔噴霧劑、口服液、口服液、凝膠和粉末。 口腔噴霧劑在預測期內的複合年增長率最高。 這主要是因為易於使用、高效且成本低廉，並且這些噴霧劑通常用於治療口乾病症。 此外，主要參與者增加產品開發正在推動該細分市場的增長。 例如，Parnell Pharmaceuticals, Inc. 於 2021 年推出了 Mouth Kote-MD，這是一種基於 MycoDelens 的口腔噴霧劑，MycoDelens 是新墨西哥理工學院創建並獲得許可的專有物質。

按年齡段劃分，市場分為成人和兒童。 其中，成人品類主導了2020年人工唾液市場的增長。 這主要是因為人工唾液在成人患者中使用得更頻繁，而口乾症狀通常在成人患者中比兒童患者更常見，所以我們認為這種情況不會很快改變。我會的。

導致該細分市場增長的另一個因素是口腔癌和食道癌引起的吞嚥困難的增加。 例如，根據世界癌症研究基金會（WCRF International）的數據，2020 年大約診斷出 604,100 例食管癌新病例。

人工唾液市場按分銷渠道分為醫院藥房、零售藥房、超市和大賣場等。 零售藥店在預測期內將經歷最高的增長。 這主要是由於藥品的可負擔性以及人口的不斷增長，導致糖尿病、中風、阿爾茨海默氏病、乾燥綜合症和艾滋病毒/艾滋病病例不斷增加，這些都會導致口乾症。 例如，根據國際糖尿病聯盟 (IDF) 的數據，到 2021 年，大約有 120 萬年輕人和青少年將患有 1 型糖尿病。

為了更好地了解人工唾液行業的市場實施情況，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、意大利、歐洲其他地區） 、亞太地區（中國、日本、印度、亞太地區其他地區）和世界其他國家。 預計北美地區在預測期內將以顯著的複合年增長率增長。 這主要是由於市場上主要參與者的存在、人們對口腔疾病的認識不斷提高、治療口乾症的產品的使用增加、可支配收入的增加、癌症和阿爾茨海默氏病患病率的增加、技術的進步以及患者人數的增加預計將促進市場增長。 例如，根據美國國家慢性病預防中心 (CDC) 的數據，2020 年有 580 萬美國人患有阿爾茨海默病。

目錄

第一章市場介紹

  • 市場定義
  • 主要目的
  • 利益相關者
  • 限制

第二章研究方法或假設

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第五章 COVID-19 對人工唾液市場的影響

第六章人工唾液市場收入，2020-2028

第 7 章按產品類型劃分的市場洞察

  • 口腔噴霧劑
  • 口服液
  • 口服液
  • 凝膠
  • 粉末

第 8 章按年齡段劃分的市場洞察

  • 成人
  • 兒童

第 9 章按分銷渠道劃分的市場洞察

  • 醫院藥房
  • 零售藥店
  • 其他

第 10 章按地區劃分的市場洞察

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區

第11章人工唾液市場動態

  • 市場驅動因素
  • 市場挑戰
  • 影響分析

第12章人工唾液市場機會

第13章人工唾液市場趨勢

第14章需求側和供給側分析

  • 需求方分析
  • 供給側分析

第 15 章價值鏈分析

第16章價格分析

第 17 章戰略洞察

第18章競爭場景

  • 競爭狀況
    • 波特五力分析

第19章公司簡介

  • GSK plc.
  • Cipla Inc.
  • Mission Pharmacal Company
  • Fresenius Kabi AG
  • Parnell Pharmaceuticals, Inc.
  • CCMed Ltd.
  • ENTOD INTERNATIONAL
  • Midatech Pharma PLC
  • Forward Science
  • Bausch Health Companies Inc.

第20章 免責事項

簡介目錄
Product Code: UMHE211945

Chewing, swallowing, digesting, and speaking all depend on saliva. Additionally, it controls bacteria growth in the mouth & reducing the risk of infection and tooth decay. While primarily water, natural saliva also contains mucous, enzymes, and electrolytes. Although artificial saliva doesn't exactly like the saliva that our glands normally create, the combination of its ingredients can help relieve symptoms like bad breath and a feeling of dryness or stickiness in the mouth.

Also, doctors may recommend the use of artificial saliva alongside medications and medical treatments, such as pain medications and chemotherapy, that are known to cause dry mouth. For instance, according to the National Cancer Institute (NIH), in 2022, it is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population and it is projected to increase by 24.4%, to 22.5 million, by 2032.

The artificial saliva market is expected to grow at a steady rate of around 13% owing to the increasing prevalence of dysphagia condition in cancer patients. Also, the expensive treatments for oral diseases in both developed & developing countries and the growing disposable income and increasing per-capita spending drive the growth of the market during the forecast period.

Based on product type, the market is segmented into oral spray, oral solution, oral liquid, gel, and powder. The oral spray category is to witness the highest CAGR during the forecast period. This is mainly due to their ease of use, efficiency & low cost, and these sprays are commonly used to treat dry mouth conditions. Also, increasing product development by key players drives the growth of the segment. For instance, Mouth Kote-MD, a mouth spray based on MycoDelens, a proprietary substance created and licensed by New Mexico Tech University, was presented by Parnell Pharmaceuticals, Inc. in 2021.

On the basis of age group, the market is bifurcated into adult and pediatric. Among these, the adult category dominated the growth of the artificial saliva market in 2020. This is mainly due to the artificial saliva being used more by adult patients and this is unlikely to change anytime soon as the dry mouth condition is typically more common in adult patients than pediatric ones.

The other factor for the growth of this segment is the growing dysphagia condition due to mouth cancer or oesophageal cancer. For instance, according to the World Cancer Research Fund (WCRF International), around 604,100 new cases of oesophageal cancer were diagnosed in 2020.

Based on distribution channel, the artificial saliva market has been classified into hospital pharmacies, retail pharmacies, supermarkets & hypermarkets, and others. The retail pharmacies category is to witness the highest growth during the forecast period. This is mainly due to the affordability of medicines and the growing population with rising cases of diabetes, stroke, Alzheimer's disease, Sjogren's syndrome, or HIV/AIDS which will cause dry mouth conditions. For instance, as per the International Diabetes Federation (IDF), around 1.2 million youngsters and youths have type 1 diabetes in 2021.

For a better understanding of the market adoption of the artificial saliva industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the availability of major market key players, rising awareness about oral diseases, growing product utilization to treat xerostomia, rising disposable incomes, increasing prevalence of cancer and Alzheimer's disease, growing technological advancements, and presence of a large patient population in the region, which is expected to aid the market growth. For instance, according to the National Center for Chronic Disease Prevention (CDC), in 2020, as many as 5.8 million Americans were living with Alzheimer's disease.

Some of the major players operating in the market include: GSK plc.; Cipla Inc.; Mission Pharmacal Company; Fresenius Kabi AG; Parnell Pharmaceuticals, Inc.; CCMed Ltd.; ENTOD INTERNATIONAL; Midatech Pharma PLC; Forward Science; Bausch Health Companies Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Artificial Saliva Market
  • 2.2. Research Methodology of the Artificial Saliva Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE ARTIFICIAL SALIVA MARKET

6 ARTIFICIAL SALIVA MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Oral Spray
  • 7.2. Oral Solution
  • 7.3. Oral Liquid
  • 7.4. Gel
  • 7.5. Powder

8 MARKET INSIGHTS BY AGE GROUP

  • 8.1. Adult
  • 8.2. Paediatric

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 9.1. Hospital Pharmacies
  • 9.2. Retail Pharmacies
  • 9.3. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 ARTIFICIAL SALIVA MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 ARTIFICIAL SALIVA MARKET OPPORTUNITIES

13 ARTIFICIAL SALIVA MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1. Competitive Landscape
    • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

  • 19.1. GSK plc.
  • 19.2. Cipla Inc.
  • 19.3. Mission Pharmacal Company
  • 19.4. Fresenius Kabi AG
  • 19.5. Parnell Pharmaceuticals, Inc.
  • 19.6. CCMed Ltd.
  • 19.7. ENTOD INTERNATIONAL
  • 19.8. Midatech Pharma PLC
  • 19.9. Forward Science
  • 19.10. Bausch Health Companies Inc.

20 DISCLAIMER